Cargando…

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure

Galectin-3 is a biomarker of heart disease. However, it remains unknown whether increase in galectin-3 levels is dependent on aetiology or disease-associated conditions and whether diseased heart releases galectin-3 into the circulation. We explored these questions in mouse models of heart disease a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, My-Nhan, Su, Yidan, Vizi, Donna, Fang, Lu, Ellims, Andris H., Zhao, Wei-Bo, Kiriazis, Helen, Gao, Xiao-Ming, Sadoshima, Junichi, Taylor, Andrew J., McMullen, Julie R., Dart, Anthony M., Kaye, David M., Du, Xiao-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973942/ https://www.ncbi.nlm.nih.gov/pubmed/29844319 http://dx.doi.org/10.1038/s41598-018-26115-y

Ejemplares similares

Stimulation of β‐adrenoceptors up‐regulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathway
por: Zhao, Wei‐Bo, et al.
Publicado: (2019)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Associations Between Fibrocytes and Postcontrast Myocardial T(1) Times in Hypertrophic Cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2013)

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction
por: Ellims, Andris H, et al.
Publicado: (2012)

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
por: Huynh, Karina, et al.
Publicado: (2010)

In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
por: Bernardo, Bianca C., et al.
Publicado: (2022)

Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
por: Horlock, Duncan, et al.
Publicado: (2021)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019)

Intermittent Fasting Reverses an Advanced Form of Cardiomyopathy
por: Mukai, Risa, et al.
Publicado: (2019)

Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
por: Bernardo, Bianca C., et al.
Publicado: (2014)

Mitochondrial Quality Control Mechanisms during Diabetic Cardiomyopathy
por: Ketenci, Melis, et al.
Publicado: (2022)

Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation
por: Bernardo, Bianca C., et al.
Publicado: (2015)

Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice
por: Wu, Wei, et al.
Publicado: (2021)

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
por: Bernardo, Bianca C., et al.
Publicado: (2016)

N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
por: Giam, Beverly, et al.
Publicado: (2017)

Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy
por: Liu, Hongqun, et al.
Publicado: (2023)

Pathological hypertrophy reverses β(2)-adrenergic receptor-induced angiogenesis in mouse heart
por: Xu, Qi, et al.
Publicado: (2015)

Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia
por: Fan, Fenling, et al.
Publicado: (2016)

Cardiomyocyte NOX4 regulates resident macrophage-mediated inflammation and diastolic dysfunction in stress cardiomyopathy
por: Vendrov, Aleksandr E., et al.
Publicado: (2023)

Circulating Galectin‐3 Is Associated With Cardiometabolic Disease in the Community
por: Nayor, Matthew, et al.
Publicado: (2015)

Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice
por: Zhu, Ning, et al.
Publicado: (2022)

Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure
por: Komici, Klara, et al.
Publicado: (2020)

Impact of sex, socio‐economic status, and remoteness on therapy and survival in heart failure
por: Gutman, Sarah J., et al.
Publicado: (2019)

Biomarker validation of cardiac magnetic resonance analysis of regional myocardial fibrosis in ischaemic heart disease
por: Costello, Benedict T, et al.
Publicado: (2016)

Prehospital opioid dose and myocardial injury in patients with ST elevation myocardial infarction
por: Fernando, Himawan, et al.
Publicado: (2020)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
por: Sundblad, Victoria, et al.
Publicado: (2021)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
por: Blair, Bailey B., et al.
Publicado: (2021)

N‐acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure
por: Giam, Beverly, et al.
Publicado: (2016)

Sirt3 targets mPTP and prevents aging in the heart
por: Sadoshima, Junichi
Publicado: (2011)

TRAF2 Mediates Physiological Mitophagy
por: Sadoshima, Junichi
Publicado: (2022)

Fasting confers stress resistance to skeletal muscle stem cells through non-metabolic actions of β-hydroxybutyrate: implications in cardioprotection and aging
por: Sadoshima, Junichi
Publicado: (2022)

Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review
por: Chaves, Ana Thereza, et al.
Publicado: (2022)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Interscalene Block in an Anesthetized Adult with Hypertrophic Obstructive Cardiomyopathy Undergoing Clavicle Fracture Reduction
por: Ho, Anthony M-H, et al.
Publicado: (2020)

Correction: Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells
por: White, David A., et al.
Publicado: (2013)

Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells
por: White, David A., et al.
Publicado: (2013)

Circulating galectin-3 promotes tumor-endothelium-adhesion by upregulating ICAM-1 in endothelium-derived extracellular vesicles
por: Wang, Lei, et al.
Publicado: (2022)

Galectin 3 and non-classical monocytes of blood as myocardial remodeling factors at ischemic cardiomyopathy
por: Chumakova, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_37cgbf1bk8pnde4h0fv1q88jmf